Patents Assigned to OHMX CORPORATION
  • Patent number: 9880121
    Abstract: In one aspect, a method for detection of a target in a sample based on the change of electrochemical cyclic voltammetry peak profile is provided. The method may involve at least two or more electroactive moieties (EAMs) comprising a transitional metal complex and an anchor group. Said transitional metal complex may be capable of reversibly or semi-reversibly transferring one or more electrons. Said anchor group may allow said EAMs to covalently attach to a solid support, forming a self-assembled monolayer (SAM) on the surface. At least one EAM may further comprises a capture ligand that can be recognized and bound by a target or a surrogate target. When a sample is introduced to an EAM, the interaction between said capture ligand and said target or surrogate target may lead to change of the properties of the SAM containing all EAMs involved. Said change can be detected by an electrochemical detection system.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: January 30, 2018
    Assignee: OHMX Corporation
    Inventors: Yijia Paul Bao, Adam G. Gaustad, Dimitra Georganopoulou, Fang Lai, Rebecca Hoo
  • Patent number: 9624522
    Abstract: The disclosure also relates to novel compositions and methods for the single, direct detection of Hemoglobin A1c percentage in a sample, using conversion of functional groups attached to a transitional metal complex, resulting in quantifiable electrochemical signal at two unique potentials, Eo1 and Eo2.
    Type: Grant
    Filed: October 17, 2012
    Date of Patent: April 18, 2017
    Assignee: OHMX Corporation
    Inventors: Adam Gaustad, Yijia Paul Bao, Dimitra Georganopoulou
  • Publication number: 20160377607
    Abstract: The disclosure relates to novel methods for performing a solution based assay reaction with an electroactive active moiety (EAM) that subsequently forms a self-assembled monolayer (SAM) utilizing the advantages of faster solution reaction kinetics, SAM protected electrode and surface based electrochemistry for electronic measurement.
    Type: Application
    Filed: June 28, 2016
    Publication date: December 29, 2016
    Applicant: OHMX Corporation
    Inventors: Yijia Paul Bao, Adam G. Gaustad
  • Patent number: 9416390
    Abstract: This invention describes methods for detecting target analytes by utilizing an electroactive moiety (EAM) that functions as a substrate for a specific enzyme. If target analyte is present, a functional group is enzymatically removed from a transition metal complex resulting in quantifiable electrochemical signal at two unique potentials, E01 and E02 that is detected through a self-assembled monolayer (SAM) on an electrode.
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: August 16, 2016
    Assignee: OHMX Corporation
    Inventors: Adam G. Gaustad, Michael J. Ahrens, Paul A. Bertin
  • Patent number: 9404883
    Abstract: The disclosure relates to novel methods for performing a solution based assay reaction with an electroactive active moiety (EAM) that subsequently forms a self-assembled monolayer (SAM) utilizing the advantages of faster solution reaction kinetics, SAM protected electrode and surface based electrochemistry for electronic measurement.
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: August 2, 2016
    Assignee: OHMX Corporation
    Inventors: Yijia Paul Bao, Adam G. Gaustad
  • Publication number: 20160202203
    Abstract: The disclosure also relates to novel methods for detection of biological targets using amplification steps in conjunction with conversion of functional groups attached to a transitional metal complex, resulting in quantifiable electrochemical signal at two unique potentials, Eo1 and Eo2.
    Type: Application
    Filed: December 18, 2015
    Publication date: July 14, 2016
    Applicant: OHMX Corporation
    Inventors: Paul A. Bertin, Michael J. Ahrens
  • Publication number: 20160178562
    Abstract: Competitive assays are provided for the detection and quantification of a target analyte utilizing a modified electro-active moiety and an enzyme, in which the target analyte and a target analog moiety are substrates. This method may be used to detect and/or quantify many classes of biological molecules and has a number of applications, e.g., in vitro diagnostic assays and devices.
    Type: Application
    Filed: December 18, 2015
    Publication date: June 23, 2016
    Applicant: OHMX Corporation
    Inventor: Adam G. Gaustad
  • Patent number: 9340567
    Abstract: The invention relates to novel compositions of 1,3-disubstituted ferrocenes useful for the modification of electrodes.
    Type: Grant
    Filed: November 2, 2012
    Date of Patent: May 17, 2016
    Assignee: OHMX Corporation
    Inventors: Paul A. Bertin, Michael J. Ahrens
  • Publication number: 20160097082
    Abstract: Methods for predicting the outcome of and monitoring prostate cancer patients using prostate specific antigen (PSA) proteolytic activity (PPA) in combination with other molecular biomarkers or other parameters are described. Methods of determining sets of parameters for use in predicting the outcome of and monitoring of prostate cancer patients are also described.
    Type: Application
    Filed: September 23, 2015
    Publication date: April 7, 2016
    Applicant: OHMX Corporation
    Inventor: Dimitra Georganopoulou
  • Patent number: 9250234
    Abstract: Described are methods for detecting a target analyte in a test sample by providing a solid support comprising an electrode comprising: (i) a self-assembled monolayer (SAM), (ii) a covalently attached electroactive active moiety (EAM) comprising a transition metal complex comprising a self-immolative moiety and a peroxide sensitive moiety (PSM), wherein said EAM has a first E0; then contacting the target analyte and said solid support under conditions wherein said target analyte reacts with a peroxide generating enzyme to generate peroxide and said self-immolative moiety is removed such that said EAM has a second E0 test sample; and then detecting said second E0 as an indication of the presence of said target analyte. Also provided are compositions for use in the preceding methods.
    Type: Grant
    Filed: January 19, 2012
    Date of Patent: February 2, 2016
    Assignee: OHMX Corporation
    Inventors: Paul A. Bertin, Michael J. Ahrens
  • Patent number: 9250203
    Abstract: The disclosure also relates to novel methods for detection of biological targets using amplification steps in conjunction with conversion of functional groups attached to a transitional metal complex, resulting in quantifiable electrochemical signal at two unique potentials, E°1 and E°2.
    Type: Grant
    Filed: January 9, 2013
    Date of Patent: February 2, 2016
    Assignee: OHMX Corporation
    Inventors: Paul A. Bertin, Michael J. Ahrens
  • Patent number: 9194836
    Abstract: The present invention is directed to electronic methods of detecting target analytes such that upon binding of the target analyte a shift in electrochemical potential is seen. This assay relies on the use of an electroactive moiety (“EAM”) that is attached to an electrode and comprises a self-immolative moiety, whose presence gives the EAM a first E0, and whose absence, upon irreversible cleavage gives the EAM a second E0. This difference is detected, and if such change occurs, it is an indication of the presence of a target analyte.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: November 24, 2015
    Assignee: OHMX Corporation
    Inventor: Paul A. Bertin
  • Publication number: 20150323484
    Abstract: In one aspect, a method for detection of a target in a sample based on the change of electrochemical cyclic voltammetry peak profile is provided. The method may involve at least two or more electroactive moieties (EAMs) comprising a transitional metal complex and an anchor group. Said transitional metal complex may be capable of reversibly or semi-reversibly transferring one or more electrons. Said anchor group may allow said EAMs to covalently attach to a solid support, forming a self-assembled monolayer (SAM) on the surface. At least one EAM may further comprises a capture ligand that can be recognized and bound by a target or a surrogate target. When a sample is introduced to an EAM, the interaction between said capture ligand and said target or surrogate target may lead to change of the properties of the SAM containing all EAMs involved. Said change can be detected by an electrochemical detection system.
    Type: Application
    Filed: April 29, 2015
    Publication date: November 12, 2015
    Applicant: OHMX Corporation
    Inventors: Yijia Paul Bao, Adam G. Gaustad, Dimitra Georganopoulou, Fang Lai, Rebecca Hoo
  • Publication number: 20150198552
    Abstract: The invention relates to novel compositions and methods for the detection of analytes using the nuclear reorganization energy, ?, of an electron transfer process.
    Type: Application
    Filed: April 16, 2014
    Publication date: July 16, 2015
    Applicant: OHMX Corporation
    Inventors: Michael J. Ahrens, Paul A. Bertin, Amanda Eckermann, Dimitra Georganopoulou, Harry B. Gray, Markus Franz Wunder
  • Publication number: 20150192538
    Abstract: The invention relates to novel compositions of disubstituted bipyridyl osmium complexes useful for the synthesis of labeled proteins, nucleic acids, and for the modification of electrodes.
    Type: Application
    Filed: January 9, 2015
    Publication date: July 9, 2015
    Applicant: OHMX CORPORATION
    Inventors: MICHAEL J. AHRENS, PAUL A. BERTIN, HARRY B. GRAY, THOMAS J. MEADE
  • Patent number: 8951400
    Abstract: The invention relates to novel compositions of disubstituted bipyridyl osmium complexes useful for the synthesis of labeled proteins, nucleic acids, and for the modification of electrodes.
    Type: Grant
    Filed: July 20, 2011
    Date of Patent: February 10, 2015
    Assignee: OHMX Corporation
    Inventors: Michael Ahrens, Paul A. Bertin, Harry B. Gray, Thomas J. Meade
  • Publication number: 20140342383
    Abstract: The invention relates to novel compositions and methods for the detection of enzymes using the nuclear reorganization energy, ?, of an electron transfer process.
    Type: Application
    Filed: May 19, 2014
    Publication date: November 20, 2014
    Applicant: OHMX Corporation
    Inventors: Paul A. Bertin, Michael J. Ahrens, Dimitra Georganopoulou, Harry B. Gray, Thomas J. Meade, Markus Franz Wunder
  • Publication number: 20140322740
    Abstract: The present invention is directed to the diagnosis of cancer associated with enzymatically active PSA in samples.
    Type: Application
    Filed: March 13, 2013
    Publication date: October 30, 2014
    Applicants: NORTHWESTERN UNIVERSITY, AN ILLINOIS NOT FOR PROFIT CORPORATION, OHMX CORPORATION
    Inventors: OHMX CORPORATION, NORTHWESTERN UNIVERSITY, AN ILLINOIS NOT FOR PROFIT CORPORATION
  • Publication number: 20140311922
    Abstract: The invention relates to novel compositions and methods for the detection of analytes using the nuclear reorganization energy, ?, of an electron transfer process.
    Type: Application
    Filed: April 16, 2014
    Publication date: October 23, 2014
    Applicant: OHMX Corporation
    Inventors: Michael J. Ahrens, Paul A. Bertin, Amanda Eckermann, Dimitra Georganopoulou, Harry B. Gray, Markus Franz Wunder
  • Patent number: 8802390
    Abstract: The invention relates to novel compositions and methods for the detection of enzymes using the nuclear reorganization energy, ?, of an electron transfer process.
    Type: Grant
    Filed: January 18, 2012
    Date of Patent: August 12, 2014
    Assignee: OHMX Corporation
    Inventors: Paul A. Bertin, Michael Ahrens, Dimitra Georganopoulou, Harry B. Gray, Thomas J. Meade, Markus Franz Wunder